menu One Stop Shop For Reports One Stop Shop For Reports
search more_vert
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Medical Devices & Supplies
      • Pharmaceuticals
  • Report Library
  • Who Trust Us
  • Datafeature
  • [email protected]
  • +1 718 618 4351 (International)
  • +91 78878 22626 (Asia)

More Results

menu One Stop Shop For Reports One Stop Shop For Reports
search more_vert
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Medical Devices & Supplies
      • Pharmaceuticals
  • Report Library
  • Who Trust Us
  • Datafeature
Home ➤ Life Science ➤ Diagnostics ➤ Aptamers Market
Aptamers Market

Aptamers Market

Published date: Aug 2022 • Formats:
Request Sample
  • Home ➤ Life Science ➤ Diagnostics ➤ Aptamers Market

Global Aptamers Market By Type (Peptide Aptamer, and Nucleic Acid Aptamer), By Application (Therapeutics, Diagnostics, Research and Development, and Other Applications), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

  • Published date: Aug 2022
  • Report ID: 38179
  • Number of Pages: 232
  • Format:
  • Overview
  • Table of Contents
  • Major Market Players
  • Request a Sample
  • account_circleAbout Me

    Aptamers Market Overview:

    The global market for aptamers was valued at USD 1,657 million in 2021. This market is expected to expand at a CAGR, of 22% between 2023-2032.

    Aptamers have been gaining attention due to their many competitive advantages. These include recent advances in purification, production, drug delivery, and drug delivery to kill target cells. These advantages include a small molecular structure, low immunogenicity, and low manufacturing costs. They also have fewer side effects than antibodies. This could fuel market growth.

    Global Aptamers Market Analysis

    Type Analysis

    The market’s largest segment was nucleic acids. This market is expected to see the most growth in the future. Numerous companies are studying the mechanism of action of nucleic acid aptamers for various disorders, such as age-related Macular Degeneration (AMD).

    In 2021, the U.S. FDA approved a written agreement, under Special Protocol Assessment (SPA), for the design and execution of GATHER2 phase 3 to IVERIC BIO. A clinical trial of Zimura for patients with GA secondary AMD. This approval is expected to boost segment growth.

    Because of its large user base for diagnostic and therapeutic purposes, the market for peptide-aptamers is expected to see significant growth. For example, the Engineering Center for Microtechnology and Diagnostics has developed a novel biosensor for multi-parametric expression testing in the preclinical diagnosis of cardiovascular disease.

    Based on the molecular recognition and peptide aptamer markers system, next-generation biochips were developed for this purpose. Researchers used data from Protein 3D software and Data Bank to create peptide-aptamers. These products could help increase the usage of peptide Aptamers.

    aptamers market

    Application Analysis

    In 2021, the research and development segment held a significant market share. The increasing demand for aptamers is coupled with increased research in this field driving the growth of the segment.

    Collaborations, partnerships, and agreements are all keys to the R&D and development of new aptamers-based diagnostic and therapeutic products. Soma Logic Ltd. and Ixaka Ltd. established research collaboration in June 2021 with the goal of supporting the development and discovery of bispecific therapeutics using aptamers.

    Due to its ability to rationally design antidotes, the therapeutics segment will experience significant market growth over the forecast period. These facts will all help the therapeutics sector to establish a strong market presence over the next period.

    Key Market Segments

    By Type

    • Peptide Aptamer
    • Nucleic Acid Aptamer

    By Application

    • Therapeutics
    • Diagnostics
    • Research and Development
    • Other Applications

    Market Dynamics

    Because of the high number of genetic variants in COVID-19, there are not currently any highly effective treatments. Despite all efforts, biotechnological strategies are promising for COVID-19 treatment. The treatment of COVID-19 may be possible using aptamers based on nucleic acids and peptides.

    To encourage the development of new treatments for COVID-19, governments have taken a variety of initiatives. Aptagen LLC received a US$ 320,000 contract from the Department of Community and Economic Development for the research and development of an innovative treatment for COVID-19 in September 2020.

    The market is expected to grow with the introduction of diagnostic kits for disease diagnosis. Optimax, which is a COVID-19 diagnosis kit, was approved by Achiko AG in December 2021. AptameX is the second generation of a diagnostic kit that was developed using DNA aptamer-based technology. It is a cost-effective and emerging healthcare diagnostic tool.

    Because of their small size, high selectivity, and specificity, aptamers are the best diagnostic and pathology products for diagnosing the disease at the cell level. Due to the rising prevalence of diseases such as cancer, CVD, and AMD, more patients may visit labs to diagnose these diseases. Aptamer-based diagnostic products are in high demand. Cancer Research U.K. estimates that 27.5 million people will be diagnosed by 2040 with cancer.

    Regional Analysis

    North America dominated aptamers in the 2021 market, accounting for 45.7% of the total revenue. The dominance of this region is due to the rising prevalence and strength of chronic diseases, as well as the growing interest in research laboratories in the area of aptamers.

    The Asia Pacific is the region expected to experience the fastest growth during the forecast period. The approval of new aptamer-based products in the region is responsible for the region’s rapid growth. Achiko AG signed an agreement with Pengurus Wilayah Nahdlatul Ulama DKI in 2020. This is the largest Islamic association in Jakarta for the sales, marketing, and distribution of AptameX’s aptamer-based COVID-19 test kit AptameX.

    aptamers market value regional share 1

    Кеу Regions and Countries covered іn thе rероrt:

    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • Germany
      • UK
      • France
      • Italy
      • Russia
      • Spain
      • Rest of Europe
    • APAC
      • China
      • Japan
      • South Korea
      • India
      • Rest of Asia-Pacific
    • South America
      • Brazil
      • Argentina
      • Rest of South America
    • MEA
      • GCC
      • South Africa
      • Israel
      • Rest of MEA

    Market Share & Key Players Analysis:

    Major players are adopting strategies for approval for new products, modifications to the product, mergers, and acquisitions. ProAxsis Limited and Aptamer Group formed a partnership in August 2021 for the development of optimal ligands to be used in the diagnostic assays developed by ProAxsis. Optimer ligands can be next-generation nucleic acids-based affinity aptamers.

    aptamers market company share analysis

    Key Market Players

    • SomaLogic
    • Aptamer Sciences Inc.
    • Aptamer Group
    • Noxxon Pharma
    • Base Pair Biotechnologies
    • Vivonics Inc.
    • Aptagen, LLC
    • TriLink Biotechnologies
    • Other Key Players

    For the Aptamers Market research study, the following years have been considered to estimate the market size:

    Attribute Report Details

    Historical Years

    2016-2020

    Base Year

    2021

    Estimated Year

    2022

    Short Term Projection Year

    2028

    Projected Year

    2023

    Long Term Projection Year

    2032

    Report Coverage

    Competitive Landscape, Revenue analysis, Company Share Analysis, Manufacturers Analysis, Volume by Manufacturers, Key Segments, Key company analysis, Market Trends, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis, strategy for existing players to grab maximum market share, and more.

    Regional Scope

    North America, Europe, Asia-Pacific, South America, Middle East & Africa

    Country Scope

    United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa

    Frequently Asked Questions (FAQ)

    Q: What is the Aptamers market size in 2021?

    A: The Aptamers market size is US$ 1,657 million in 2021.

    Q: What is the CAGR for the Aptamers market?

    A: The Aptamers market is expected to grow at a CAGR of 22% during 2023-2032.

    Q: What are the segments covered in the Aptamers market report?

    A: Market.US has segmented the Global Aptamers Market Value (US$ Mn) Analysis by Region, 2022 market by geographic (North America, Europe, APAC, South America, and Middle East and Africa). By Type, market has been segmented into peptide aptamer, and nucleic acid aptamer. By Application, market has been further divided into therapeutics, diagnostics, research and development, and other applications.

    Q: Who are the key players in the Aptamers market?

    A: SomaLogic, Aptamer Sciences Inc., Aptamer Group, Noxxon Pharma, Base Pair Biotechnologies, Vivonics Inc., Aptagen LLC, TriLink Biotechnologies, and Other Key Players

    Q: Which region is more attractive for vendors in the Aptamers market?

    A: North America accounted for the highest revenue share of 45.7% among the other regions. Therefore, the Aptamers market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

    Q: What are the key markets for Aptamers?

    A: Key markets for Aptamers are The US, China, Japan, India, Brazil, Germany, UK, France, Italy, Spain, etc.

    Q: Which segment has the largest share in the Aptamers market?

    A: In the aptamers market, vendors should focus on grabbing business opportunities from the nucleic acid aptamer type segment as it accounted for the largest market share in the base year.

    Aptamers Market
    Aptamers Market
    Published date: Aug 2022 • Formats:
    add_shopping_cartBuy Now get_appDownload Sample
    keyboard_arrow_up
  • account_circleAbout Me
  • ondemand_videoVideos
    • SomaLogic
    • Aptamer Sciences Inc.
    • Aptamer Group
    • Noxxon Pharma
    • Base Pair Biotechnologies
    • Vivonics Inc.
    • Aptagen, LLC
    • TriLink Biotechnologies
    • Other Key Players
  • settingsSettings

Related Reports

  • Automotive Repair and Maintenance Services Market

    • ★★★★★
      ★★★★★
    • (42)
  • Methyl Methacrylate Market

    • ★★★★★
      ★★★★★
    • (78)
  • Mobile Tomography Market

    • ★★★★★
      ★★★★★
    • (37)
  • Pyrotechnics Devices Market

    • ★★★★★
      ★★★★★
    • (49)
  • Machine Glazed Kraft Release Liner Market

    • ★★★★★
      ★★★★★
    • (43)
  • Tissue Banking Equipment Market

    • ★★★★★
      ★★★★★
    • (14)

Our Clients

  • Our Clients

Inquiry Before Buying


Aptamers Market
  • 38179
  • Aug 2022
    • ★★★★★
      ★★★★★
    • (42)
  • US $5,999
    US $4,499
  • US $7,999
    US $4,999
  • US $9,999
    US $5,499
Buy Now
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$5,999
$4,499
USD / per unit
save 25%
Multi User
$7,999
$4,999
USD / per unit
save 38%
Corporate User
$9,999
$5,499
USD / per unit
save 45%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
  • location_on420 Lexington Avenue, Suite 300 New York City, NY 10170,
    United States
  • phone+1 718 618 4351 (International)
  • phone+91 78878 22626 (Asia)
  • email[email protected]
  • Facebook Logo
  • Twitter Logo
  • LinkedIn Logo
Find Help
  • Contact Us
  • How to Order
Legal
  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions
Explore
  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts
  • Companies
  • Report Library
Secured Payment Options
Secured Payment Options

© 2023 Market.Us. All Rights Reserved.